BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Talwalkar JA, Gores GJ. Diagnosis and staging of hepatocellular carcinoma. Gastroenterology. 2004;127:S126-S132. [PMID: 15508076 DOI: 10.1053/j.gastro.2004.09.026] [Cited by in Crossref: 88] [Cited by in F6Publishing: 70] [Article Influence: 4.9] [Reference Citation Analysis]
Number Citing Articles
1 Lee NPY, Leung K, Cheung N, Lam BY, Xu MZ, Sham PC, Lau GK, Poon RTP, Fan ST, Luk JM. Comparative proteomic analysis of mouse livers from embryo to adult reveals an association with progression of hepatocellular carcinoma. Proteomics 2008;8:2136-49. [DOI: 10.1002/pmic.200700590] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 2.1] [Reference Citation Analysis]
2 Singh P, Erickson RA, Mukhopadhyay P, Gopal S, Kiss A, Khan A, Ulf Westblom T. EUS for detection of the hepatocellular carcinoma: results of a prospective study. Gastrointest Endosc 2007;66:265-73. [PMID: 17543307 DOI: 10.1016/j.gie.2006.10.053] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 2.5] [Reference Citation Analysis]
3 Modo M, Hoehn M, Bulte JW. Cellular MR Imaging. Mol Imaging 2005;4:153535002005051. [DOI: 10.1162/15353500200505145] [Cited by in Crossref: 237] [Cited by in F6Publishing: 148] [Article Influence: 13.9] [Reference Citation Analysis]
4 Inagaki Y, Xu HL, Hasegawa K, Aoki T, Beck Y, Sugawara Y, Tang W, Kokudo N. Des-gamma-carboxyprothrombin in patients with hepatocellular carcinoma and liver cirrhosis. J Dig Dis. 2011;12:481-488. [PMID: 22118699 DOI: 10.1111/j.1751-2980.2011.00521.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
5 Blum HE. Hepatocellular carcinoma: therapy and prevention. World J Gastroenterol. 2005;11:7391-7400. [PMID: 16437707 DOI: 10.3748/wjg.v11.i47.7391] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 94] [Article Influence: 2.3] [Reference Citation Analysis]
6 Wich C, Agaimy A, Strobel D, Wissniowski TT, Hartmann A, Ocker M. Sustained treatment response of metastatic hepatocellular carcinoma with bevacizumab and sorafenib. World J Gastroenterol 2010; 16(28): 3592-3596 [PMID: 20653070 DOI: 10.3748/wjg.v16.i28.3592] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
7 Buijs N, Oosterink JE, Jessup M, Schierbeek H, Stolz DB, Houdijk AP, Geller DA, van Leeuwen PA. A new key player in VEGF-dependent angiogenesis in human hepatocellular carcinoma: dimethylarginine dimethylaminohydrolase 1. Angiogenesis 2017;20:557-65. [PMID: 28741166 DOI: 10.1007/s10456-017-9567-4] [Cited by in Crossref: 38] [Cited by in F6Publishing: 44] [Article Influence: 7.6] [Reference Citation Analysis]
8 Tangkijvanich P, Thong-ngam D, Mahachai V, Theamboonlers A, Poovorawan Y. Role of serum interleukin-18 as a prognostic factor in patients with hepatocellular carcinoma. World J Gastroenterol 2007; 13(32): 4345-4349 [PMID: 17708609 DOI: 10.3748/wjg.v13.i32.4345] [Cited by in CrossRef: 33] [Cited by in F6Publishing: 33] [Article Influence: 2.2] [Reference Citation Analysis]
9 Morris MA, Young LS, Dawson CW. DNA tumour viruses promote tumour cell invasion and metastasis by deregulating the normal processes of cell adhesion and motility. Eur J Cell Biol 2008;87:677-97. [PMID: 18468721 DOI: 10.1016/j.ejcb.2008.03.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
10 Girotra M, Soota K, Dhaliwal AS, Abraham RR, Garcia-Saenz-de-Sicilia M, Tharian B. Utility of endoscopic ultrasound and endoscopy in diagnosis and management of hepatocellular carcinoma and its complications: What does endoscopic ultrasonography offer above and beyond conventional cross-sectional imaging? World J Gastrointest Endosc 2018; 10(2): 56-68 [PMID: 29467916 DOI: 10.4253/wjge.v10.i2.56] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
11 Sturgeon CM, Duffy MJ, Hofmann BR, Lamerz R, Fritsche HA, Gaarenstroom K, Bonfrer J, Ecke TH, Grossman HB, Hayes P, Hoffmann RT, Lerner SP, Löhe F, Louhimo J, Sawczuk I, Taketa K, Diamandis EP; National Academy of Clinical Biochemistry. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in liver, bladder, cervical, and gastric cancers. Clin Chem 2010;56:e1-48. [PMID: 20207771 DOI: 10.1373/clinchem.2009.133124] [Cited by in Crossref: 146] [Cited by in F6Publishing: 119] [Article Influence: 12.2] [Reference Citation Analysis]
12 Shen Y, Li X, Su Y, Badshah SA, Zhang B, Xue Y, Shang P. HAMP Downregulation Contributes to Aggressive Hepatocellular Carcinoma via Mechanism Mediated by Cyclin4-Dependent Kinase-1/STAT3 Pathway. Diagnostics (Basel) 2019;9:E48. [PMID: 31052210 DOI: 10.3390/diagnostics9020048] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
13 Tu K, Liu Z, Yao B, Han S, Yang W. MicroRNA-519a promotes tumor growth by targeting PTEN/PI3K/AKT signaling in hepatocellular carcinoma. Int J Oncol 2016;48:965-74. [PMID: 26708293 DOI: 10.3892/ijo.2015.3309] [Cited by in Crossref: 69] [Cited by in F6Publishing: 70] [Article Influence: 9.9] [Reference Citation Analysis]
14 Hsiang CY, Wu SL, Chen JC, Lo HY, Li CC, Chiang SY, Wu HC, Ho TY. Acetaldehyde induces matrix metalloproteinase-9 gene expression via nuclear factor-kappaB and activator protein 1 signaling pathways in human hepatocellular carcinoma cells: Association with the invasive potential. Toxicol Lett. 2007;171:78-86. [PMID: 17543481 DOI: 10.1016/j.toxlet.2007.04.009] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 1.7] [Reference Citation Analysis]
15 Waly Raphael S, Yangde Z, Yuxiang C. Hepatocellular carcinoma: focus on different aspects of management. ISRN Oncol 2012;2012:421673. [PMID: 22655206 DOI: 10.5402/2012/421673] [Cited by in Crossref: 25] [Cited by in F6Publishing: 45] [Article Influence: 2.5] [Reference Citation Analysis]
16 Zhu Q, Li N, Han Q, Li Z, Zhang G, Li F, Zhang P, Chen J, Lv Y, Liu Z. Single-nucleotide polymorphism at CYP27B1-1260, but not VDR Taq I, is possibly associated with persistent hepatitis B virus infection. Genet Test Mol Biomarkers 2012;16:1115-21. [PMID: 22963605 DOI: 10.1089/gtmb.2012.0148] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
17 Li N, Zhu Q, Li Z, Han Q, Zhang G, Chen J, Lv Y, Xing F, Chen Y, Zeng X, Liu Z. IL17A gene polymorphisms, serum IL-17A and IgE levels, and hepatocellular carcinoma risk in patients with chronic hepatitis B virus infection. Mol Carcinog 2014;53:447-57. [PMID: 23280722 DOI: 10.1002/mc.21992] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 2.9] [Reference Citation Analysis]
18 Catalano OA, Choy G, Zhu A, Hahn PF, Sahani DV. Differentiation of malignant thrombus from bland thrombus of the portal vein in patients with hepatocellular carcinoma: application of diffusion-weighted MR imaging. Radiology. 2010;254:154-162. [PMID: 20032150 DOI: 10.1148/radiol.09090304] [Cited by in Crossref: 128] [Cited by in F6Publishing: 114] [Article Influence: 10.7] [Reference Citation Analysis]
19 Lin C, Chen J, Liu C, Lee P, Chen P, Lai M, Kao J, Chen D. Clinicopathological differences between hepatitis B viral genotype B- and C-related resectable hepatocellular carcinoma. J Viral Hepat 2007;14:64-9. [DOI: 10.1111/j.1365-2893.2006.00776.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
20 Wang K, Liu J, Yan ZL, Li J, Shi LH, Cong WM, Xia Y, Zou QF, Xi T, Shen F, Wang HY, Wu MC. Overexpression of aspartyl-(asparaginyl)-beta-hydroxylase in hepatocellular carcinoma is associated with worse surgical outcome. Hepatology 2010;52:164-73. [PMID: 20578260 DOI: 10.1002/hep.23650] [Cited by in Crossref: 61] [Cited by in F6Publishing: 67] [Article Influence: 5.1] [Reference Citation Analysis]
21 Luciani A, Allice O, Zegai B, Djabbari M, Anglade MC, Rahmouni A, Cherqui D, Tran-Van-Nhieu J, Aubé C. [Imaging nodules within cirrhotic liver: how do I do it?]. J Radiol 2007;88:1073-90. [PMID: 17762836 DOI: 10.1016/s0221-0363(07)89920-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Levy MJ, Zhang L, Gleeson FC. Electronic Clinical Challenges and Images in GI. Gastroenterology 2009;136:e1-3. [DOI: 10.1053/j.gastro.2008.12.036] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
23 Legoux J, Bedenne L, Seitz J, Pezet D, Rougier P, Bouché O, Barbare J, André T, Malka D, Cadiot G, Ruskoné-foumestraux A, Landi B, Peiffert D, Ducreux M, Louvet C, Dorval E. Quels changements dans le Thésaurus National de Cancérologie Digestive en 2005 ? Gastroentérologie Clinique et Biologique 2006;30:1191-5. [DOI: 10.1016/s0399-8320(06)73510-2] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
24 Banerjee I, Fisher PB, Sarkar D. Astrocyte elevated gene-1 (AEG-1): A key driver of hepatocellular carcinoma (HCC). Adv Cancer Res 2021;152:329-81. [PMID: 34353442 DOI: 10.1016/bs.acr.2021.05.003] [Reference Citation Analysis]
25 Spangenberg HC, Thimme R, Blum HE. Advances in prevention and diagnosis of hepatocellular carcinoma. Expert Rev Gastroenterol Hepatol 2008;2:425-33. [PMID: 19072390 DOI: 10.1586/17474124.2.3.425] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
26 Giannini EG, Risso D, Testa R, Trevisani F, Di Nolfo MA, Del Poggio P, Benvegnù L, Ludovico Rapaccini G, Farinati F, Zoli M. Prevalence and prognostic significance of the presence of esophageal varices in patients with hepatocellular carcinoma. Clin Gastroenterol Hepatol. 2006;4:1378-1384. [PMID: 17059899 DOI: 10.1016/j.cgh.2006.08.011] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 3.1] [Reference Citation Analysis]
27 Bertino G, Ardiri A, Malaguarnera M, Malaguarnera G, Bertino N, Calvagno GS. Hepatocellualar carcinoma serum markers. Semin Oncol. 2012;39:410-433. [PMID: 22846859 DOI: 10.1053/j.seminoncol.2012.05.001] [Cited by in Crossref: 103] [Cited by in F6Publishing: 101] [Article Influence: 10.3] [Reference Citation Analysis]
28 Knüchel-Clarke R, Lutz HH, Floege J, Marx N, Brümmendorf TH, Trautwein C. [When only the pathologist may help. Limitation and possibilities of biopsies in Internal Medicine]. Internist (Berl) 2010;51:463-72. [PMID: 20195562 DOI: 10.1007/s00108-009-2453-4] [Reference Citation Analysis]
29 Gomaa AI, Khan SA, Leen EL, Waked I, Taylor-Robinson SD. Diagnosis of hepatocellular carcinoma. World J Gastroenterol 2009; 15(11): 1301-1314 [PMID: 19294759 DOI: 10.3748/wjg.15.1301] [Cited by in CrossRef: 104] [Cited by in F6Publishing: 87] [Article Influence: 8.0] [Reference Citation Analysis]
30 Shahrokhi P, Masteri Farahani A, Tamaddondar M, Rezazadeh F. The utility of radiolabeled PSMA ligands for tumor imaging. Chem Biol Drug Des 2021. [PMID: 34472217 DOI: 10.1111/cbdd.13946] [Reference Citation Analysis]
31 Lee NP, Cheung ST, Poon RT, Fan ST, Luk JM. Genomic and proteomic biomarkers for diagnosis and prognosis of hepatocellular carcinoma. Biomark Med 2007;1:273-84. [PMID: 20477402 DOI: 10.2217/17520363.1.2.273] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
32 Roberts SK, Kemp W. Hepatocellular carcinoma in an Australian tertiary referral hospital 1975-2002: change in epidemiology and clinical presentation. J Gastroenterol Hepatol. 2007;22:191-196. [PMID: 17295870 DOI: 10.1111/j.1440-1746.2006.04459.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
33 Kornberg A. Liver transplantation for hepatocellular carcinoma beyond Milan criteria: multidisciplinary approach to improve outcome. ISRN Hepatol. 2014;25:154-159. [PMID: 27335840 DOI: 10.1155/2014/706945] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
34 Massironi S, Fraquelli M, Paggi S, Sangiovanni A, Conte D, Sciola V, Ciafardini C, Colombo M, Peracchi M. Chromogranin A levels in chronic liver disease and hepatocellular carcinoma. Dig Liver Dis. 2009;41:31-35. [PMID: 18762462 DOI: 10.1016/j.dld.2008.05.002] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
35 Hsieh MJ, Lu CH, Tsai NW, Lui CC, Chuang YC, Huang CR, Chen SF, Chang CC, Chang HW, Chang WN. Prediction, clinical characteristics and prognosis of intracerebral hemorrhage in hepatocellular carcinoma patients with intracerebral metastasis. J Clin Neurosci 2009;16:394-8. [PMID: 19147364 DOI: 10.1016/j.jocn.2008.05.010] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
36 Sutcliffe R, Maguire D, Portmann B, Rela M, Heaton N. Selection of patients with hepatocellular carcinoma for liver transplantation. British Journal of Surgery 2006;93:11-8. [DOI: 10.1002/bjs.5198] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 1.9] [Reference Citation Analysis]
37 Chang ML, Lin YJ, Chang CJ, Yeh C, Chen TC, Yeh TS, Lee WC, Yeh CT. Occult and Overt HBV Co-Infections Independently Predict Postoperative Prognosis in HCV-Associated Hepatocellular Carcinoma. PLoS One. 2013;8:e64891. [PMID: 23805180 DOI: 10.1371/journal.pone.0064891] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
38 Kwon RS, Sahani DV, Brugge WR. Gastrointestinal cancer imaging: deeper than the eye can see. Gastroenterology. 2005;128:1538-1553. [PMID: 15887150 DOI: 10.1053/j.gastro.2005.03.034] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
39 Kleek EJV, Schwartz JM, Rayhill SC, Rosen HR, Cotler SJ. Liver Transplantation for Hepatocellular Carcinoma: A Survey of Practices. Journal of Clinical Gastroenterology 2006;40:643-7. [DOI: 10.1097/00004836-200608000-00018] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
40 Spangenberg HC, Thimme R, Blum HE. Targeted therapy for hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol 2009;6:423-32. [DOI: 10.1038/nrgastro.2009.86] [Cited by in Crossref: 80] [Cited by in F6Publishing: 81] [Article Influence: 6.2] [Reference Citation Analysis]
41 Ou DP, Tao YM, Tang FQ, Yang LY. The hepatitis B virus X protein promotes hepatocellular carcinoma metastasis by upregulation of matrix metalloproteinases. Int J Cancer 2007;120:1208-14. [PMID: 17187364 DOI: 10.1002/ijc.22452] [Cited by in Crossref: 67] [Cited by in F6Publishing: 64] [Article Influence: 4.5] [Reference Citation Analysis]
42 Beaugrand M, Trinchet JC. [Non-surgical treatment of hepatocellular carcinoma. An overview]. Cancer Radiother 2005;9:464-9. [PMID: 16236541 DOI: 10.1016/j.canrad.2005.09.017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
43 Schaudt A, Kriener S, Schwarz W, Wullstein C, Zangos S, Vogl T, Mehrabi A, Fonouni H, Bechstein WO, Golling M. Role of transarterial chemoembolization for hepatocellular carcinoma before liver transplantation with special consideration of tumor necrosis. Clin Transplant 2009;23 Suppl 21:61-7. [PMID: 19930318 DOI: 10.1111/j.1399-0012.2009.01111.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
44 Quivrin M, Mornex F, Enachescu C, Martin E, Ligey-bartolomeu A, Nouhaud E, Chamois J, Maingon P, Créhange G. Tumeurs primitives hépatiques. Cancer/Radiothérapie 2010;14:S103-10. [DOI: 10.1016/s1278-3218(10)70013-5] [Cited by in Crossref: 7] [Article Influence: 0.6] [Reference Citation Analysis]
45 Altekruse SF, McGlynn KA, Dickie LA, Kleiner DE. Hepatocellular carcinoma confirmation, treatment, and survival in surveillance, epidemiology, and end results registries, 1992-2008. Hepatology 2012;55:476-82. [PMID: 21953588 DOI: 10.1002/hep.24710] [Cited by in Crossref: 155] [Cited by in F6Publishing: 162] [Article Influence: 15.5] [Reference Citation Analysis]
46 Prabhu VR, Burt AD. Pathology of liver tumours. Surgery (Oxford) 2007;25:10-5. [DOI: 10.1016/j.mpsur.2006.11.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
47 Feng H, Li X, Niu D, Chen WN. Protein profile in HBx transfected cells: a comparative iTRAQ-coupled 2D LC-MS/MS analysis. J Proteomics 2010;73:1421-32. [PMID: 20026004 DOI: 10.1016/j.jprot.2009.12.004] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
48 Niravath P, Hayes T, Hilsenbeck S. Utility of screening for hepatocellular carcinoma among cirrhotics. Frontline Gastroenterol 2011;2:182-7. [PMID: 28839606 DOI: 10.1136/fg.2010.003244] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
49 Rizvi S, Camci C, Yong Y, Parker G, Shrago S, Stokes K, Wright H, Sebastian A, Gurakar A. Is post-Lipiodol CT better than i.v. contrast CT scan for early detection of HCC? A single liver transplant center experience. Transplant Proc 2006;38:2993-5. [PMID: 17112883 DOI: 10.1016/j.transproceed.2006.08.125] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
50 Goodman ZD, Terracciano LM, Wee A. Tumours and tumour-like lesions of the liver. MacSween's Pathology of the Liver. Elsevier; 2012. pp. 761-851. [DOI: 10.1016/b978-0-7020-3398-8.00014-3] [Cited by in Crossref: 21] [Article Influence: 2.1] [Reference Citation Analysis]
51 Chang ML, Lin SM, Yeh CT. HURP expression-assisted risk scores identify prognosis distinguishable subgroups in early stage liver cancer. PLoS One 2011;6:e26323. [PMID: 22022601 DOI: 10.1371/journal.pone.0026323] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
52 Montano-Loza AJ, Carpenter HA, Czaja AJ. Predictive factors for hepatocellular carcinoma in type 1 autoimmune hepatitis. Am J Gastroenterol. 2008;103:1944-1951. [PMID: 18564111 DOI: 10.1111/j.1572-0241.2008.01922.x] [Cited by in Crossref: 65] [Cited by in F6Publishing: 54] [Article Influence: 4.6] [Reference Citation Analysis]
53 Jiang L, Gu T, Liu F, Luan L, Shi H. A Case of Oral Metastasis From Hepatocellular Carcinoma Displayed on 18F-FDG PET/CT Imaging. Clin Nucl Med 2016;41:72-3. [PMID: 26359556 DOI: 10.1097/RLU.0000000000000941] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
54 Siripongsakun S, Wei SH, Lin S, Chen J, Raman SS, Sayre J, Tong MJ, Lu DS. Evaluation of alpha-fetoprotein in detecting hepatocellular carcinoma recurrence after radiofrequency ablation: Evaluation of alpha-fetoprotein. J Gastroenterol Hepatol 2014;29:157-64. [DOI: 10.1111/jgh.12438] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
55 Lin C, Kao J. Hepatitis B viral load as a prognostic factor for patients with unresectable hepatocellular carcinoma. Future Virology 2007;2:441-3. [DOI: 10.2217/17460794.2.5.441] [Reference Citation Analysis]
56 Arrieta O, Cacho B, Morales-Espinosa D, Ruelas-Villavicencio A, Flores-Estrada D, Hernández-Pedro N. The progressive elevation of alpha fetoprotein for the diagnosis of hepatocellular carcinoma in patients with liver cirrhosis. BMC Cancer. 2007;7:28. [PMID: 17288606 DOI: 10.1186/1471-2407-7-28] [Cited by in Crossref: 57] [Cited by in F6Publishing: 56] [Article Influence: 3.8] [Reference Citation Analysis]
57 Chen SF, Tsai NW, Lui CC, Lu CH, Huang CR, Chuang YC, Cheng YF, Kuo CH, Chang WN. Hepatocellular carcinoma presenting as nervous system involvement. Eur J Neurol 2007;14:408-12. [PMID: 17388989 DOI: 10.1111/j.1468-1331.2007.01681.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
58 Hsiao SY, Chen SF, Chang CC, Lin CH, Chang WN, Lu CH, Chuang YC, Tsai NW. Central nervous system involvement in hepatocellular carcinoma: clinical characteristics and comparison of intracranial and spinal metastatic groups. J Clin Neurosci 2011;18:364-8. [PMID: 21247770 DOI: 10.1016/j.jocn.2010.04.037] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
59 Park JW, An M, Choi JI, Kim YI, Kim SH, Lee WJ, Park SJ, Hong EK, Kim CM. Accuracy of clinical criteria for the diagnosis of hepatocellular carcinoma without biopsy in a Hepatitis B virus-endemic area. J Cancer Res Clin Oncol 2007;133:937-43. [PMID: 17516087 DOI: 10.1007/s00432-007-0232-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
60 Paul SB, Gulati MS, Sreenivas V, Madan K, Gupta AK, Mukhopadhyay S, Acharya SK. Evaluating patients with cirrhosis for hepatocellular carcinoma: value of clinical symptomatology, imaging and alpha-fetoprotein. Oncology. 2007;72 Suppl 1:117-123. [PMID: 18087192 DOI: 10.1159/000111717] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 2.4] [Reference Citation Analysis]
61 Zhang C, Peng Y, Yang F, Qin R, Liu W, Zhang C. PCDH8 is Frequently Inactivated by Promoter Hypermethylation in Liver Cancer: Diagnostic and Clinical Significance. J Cancer 2016;7:446-52. [PMID: 26918058 DOI: 10.7150/jca.13065] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
62 Ceyhan K, Kupana SA, Bektaş M, Coban S, Tuzun A, Cınar K, Soykan I, Ormeci N, Erdogan N, Erekul S, Kose K. The diagnostic value of on-site cytopathological evaluation and cell block preparation in fine-needle aspiration cytology of liver masses. Cytopathology 2006;17:267-74. [DOI: 10.1111/j.1365-2303.2006.00381.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
63 Spangenberg HC, Thimme R, Blum HE. Evolving therapies in the treatment of hepatocellular carcinoma. Biologics 2008;2:453-62. [PMID: 19707376 DOI: 10.2147/btt.s3254] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
64 Yan W, Chang Y, Liang X, Cardinal JS, Huang H, Thorne SH, Monga SP, Geller DA, Lotze MT, Tsung A. High-mobility group box 1 activates caspase-1 and promotes hepatocellular carcinoma invasiveness and metastases. Hepatology. 2012;55:1863-1875. [PMID: 22234969 DOI: 10.1002/hep.25572] [Cited by in Crossref: 161] [Cited by in F6Publishing: 152] [Article Influence: 16.1] [Reference Citation Analysis]
65 Stefanczyk-sapieha L, Fainsinger RL. Hepatocellular Carcinoma: Misdiagnosis or Spontaneous Remission? J Palliat Care 2008;24:55-9. [DOI: 10.1177/082585970802400108] [Reference Citation Analysis]
66 Stefos A, Gatselis N, Zachou K, Rigopoulou E, Hadjichristodoulou C, Dalekos GN. Descriptive epidemiology of chronic hepatitis B by using data from a hepatitis registry in Central Greece. Eur J Intern Med. 2009;20:35-43. [PMID: 19237090 DOI: 10.1016/j.ejim.2008.04.023] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
67 Liao R, Zhang D, Li X, Ma J, Yu J, Yang C, Xiong H, Zhou B, Huang X, Tang Z. A Preliminary Study on the Diagnostic Efficacy of Proton Magnetic Resonance Spectroscopy at 3.0T in Rabbit With VX2 Liver Tumor. Technol Cancer Res Treat 2021;20:15330338211036852. [PMID: 34372732 DOI: 10.1177/15330338211036852] [Reference Citation Analysis]
68 Alsohaibani F, Porter G, Al-Ashgar H, Walsh M, Berry R, Molinari M, Peltekian KM. Comparison of cancer care for hepatocellular carcinoma at two tertiary-care referral centers from high and low endemic regions for viral hepatitis. J Gastrointest Cancer 2011;42:228-35. [PMID: 20809396 DOI: 10.1007/s12029-010-9200-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
69 Wang Y, Liu YH, Mai SJ, He LJ, Liao YJ, Deng HX, Guan XY, Zeng YX, Kung HF, Xie D. Evaluation of serum clusterin as a surveillance tool for human hepatocellular carcinoma with hepatitis B virus related cirrhosis. J Gastroenterol Hepatol. 2010;25:1123-1128. [PMID: 20594228 DOI: 10.1111/j.1440-1746.2009.06205.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
70 Fu X, Li X, Han D, Yang W, Liu C, Fan L, Ding S, Ma Y. Ultrasensitive electrochemical biosensor for des-gamma-carboxy prothrombin analysis based on core-shell Pd@PtCu-alloy loaded on WS2 nanosheet. Journal of Electroanalytical Chemistry 2021;888:115213. [DOI: 10.1016/j.jelechem.2021.115213] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
71 Guiu B, Loffroy R, Ben Salem D, Lepage C, Guiu S, Aho S, Jouve JL, Krausé D, Cercueil JP. Combined SPIO-gadolinium magnetic resonance imaging in cirrhotic patients: negative predictive value and role in screening for hepatocellular carcinoma. Abdom Imaging 2008;33:520-8. [PMID: 17912584 DOI: 10.1007/s00261-007-9327-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
72 Dong QZ, Zhang XF, Zhao Y, Jia HL, Zhou HJ, Dai C, Sun HJ, Qin Y, Zhang WD, Ren N. Osteopontin promoter polymorphisms at locus -443 significantly affect the metastasis and prognosis of human hepatocellular carcinoma. Hepatology. 2013;57:1024-1034. [PMID: 23079960 DOI: 10.1002/hep.26103] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 4.1] [Reference Citation Analysis]
73 Liu C, Xiao GQ, Yan LN, Li B, Jiang L, Wen TF, Wang WT, Xu MQ, Yang JY. Value of α-fetoprotein in association with clinicopathological features of hepatocellular carcinoma. World J Gastroenterol 2013; 19(11): 1811-1819 [PMID: 23555170 DOI: 10.3748/wjg.v19.i11.1811] [Cited by in CrossRef: 67] [Cited by in F6Publishing: 68] [Article Influence: 7.4] [Reference Citation Analysis]